TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $191,322 | +18.2% | 13,774 | +31.6% | 0.01% | 0.0% |
| Q3 2023 | $161,910 | -26.2% | 10,466 | -25.1% | 0.01% | -22.2% |
| Q2 2023 | $219,501 | -1.5% | 13,972 | +3.3% | 0.01% | -10.0% |
| Q1 2023 | $222,909 | -2.2% | 13,526 | -23.0% | 0.01% | -16.7% |
| Q3 2022 | $228,000 | +21.3% | 17,574 | +31.3% | 0.01% | +20.0% |
| Q2 2022 | $188,000 | +18.2% | 13,388 | +20.5% | 0.01% | +66.7% |
| Q1 2022 | $159,000 | – | 11,114 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
| TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
| Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
| Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
| Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
| Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
| Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
| Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |